Early operable breast cancer in elderly women treated with an aromatase inhibitor letrozole as sole therapy.

Abstract

Letrozole is a reasonable alternative in elderly women with early ER/PR-positive invasive breast cancer who are unfit or unwilling to undergo standard therapy.

Full Text

DOI - British journal of cancer (DOI)
Swets Information Services - full-text online
Nature Publishing Group - full-text online
EBSCO - full-text online

Subjects

Similar articles

Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer. (2009-08-20)
Letrozole compared with tamoxifen for elderly patients with endocrine-responsive early breast cancer: the BIG 1-98 trial. (2008-04-18)
Effectiveness of a letter notification program for women with early-stage breast cancer eligible for extended adjuvant letrozole. (2009-03-20)
Randomized phase II trial of letrozole and letrozole plus low-dose metronomic oral cyclophosphamide as primary systemic treatment in elderly breast cancer patients. (2006-07-31)
Cardiovascular adverse events during adjuvant endocrine therapy for early breast cancer using letrozole or tamoxifen: safety analysis of BIG 1-98 trial. (2007-12-19)
Beyond tamoxifen: extended and late extended endocrine therapy in postmenopausal early breast cancer. (2008-03-18)
Letrozole: advancing hormone therapy in breast cancer. (2012-11-27)
Investigation of herb-drug interactions with ginkgo biloba in women receiving hormonal treatment for early breast cancer. (2013-03-22)
Differences between the non-steroidal aromatase inhibitors anastrozole and letrozole--of clinical importance? (2011-03-30)

Authors

Publication date

2011-12-07

Journal

British journal of cancer
Br J Cancer (1532-1827)

Journal topics

Language

Eng.

Copyright

British journal of cancer

Breast Unit, Luton & Dunstable Hospital NHS Foundation Trust, Lewsey Road, Bedfordshire, Luton, UK. ravi_surgery [at] hotmail.com

Release reference

Br J Cancer. 2011 Dec;105(12):1825-9

Related books

Español | English

© Galenicom 1999-2013